Document is current

Article History

Received: 29 April 2022

Revised: 7 October 2022

Accepted: 12 October 2022

First Online: 15 November 2022

Declarations

:

: The scientific guarantor of this publication is Hyoung Jung Kim.

: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

: We consulted an expert statistician (Jung Bok Lee, Associate Professor, Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea) for this study.

: Written informed consent was waived by the Institutional Review Board.

: Institutional Review Board approval was obtained.

: Study subjects or cohorts have been previously reported in the articles below.Kim DW, Kim HJ, Kim KW, et al (2015) Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol 25:1375-1383Kim DW, Kim HJ, Kim KW et al (2016) Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients. Eur Radiol 26:1320-1329Choi SH, Kim HJ, Kim SY et al (2017) Computed tomography features predictive of lymph node involvement in patients with a nonfunctioning pancreatic neuroendocrine tumor. Pancreas 46:1056-1063Park HJ, Kim HJ, Kim KW et al (2020) Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT. Eur Radiol 30:4772-4782

: • retrospective• observational study• multicenter study